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Abstract
Background: Remodeling of lung tissues during the process of granuloma formation requires significant
restructuring of the extra-cellular matrix and cathepsins K, L and S are among the strongest extra-cellular matrix
degrading enzymes. Cathepsin K is highly expressed in various pathological granulomatous infiltrates and all three
enzymes in their active form are detected in bronchoalveolar lavage fluids from patients with sarcoidosis.
Granulomatous inflammation is driven by T-cell response and cathepsins S and L are actively involved in the
regulation of antigen presentation and T-cell selection. Here, we show that the disruption of the activities of
cathepsins K, L, or S affects the development of lung granulomas in a mouse model of sarcoidosis.
Methods: Apolipoprotein E-deficient mice lacking cathepsin K or L were fed Paigen diet for 16 weeks and lungs
were analyzed and compared with their cathepsin-expressing littermates. The role of cathepsin S in the
development of granulomas was evaluated using mice treated for 8 weeks with a potent and selective cathepsin S
inhibitor.
Results: When compared to wild-type litters, more cathepsin K-deficient mice had lung granulomas, but
individually affected mice developed smaller granulomas that were present in lower numbers. The absence of
cathepsin K increased the number of multinucleated giant cells and the collagen content in granulomas. Cathepsin
L deficiency resulted in decreased size and number of lung granulomas. Apoe-/- mice treated with a selective
cathepsin S inhibitor did not develop lung granulomas and only individual epithelioid cells were observed.
Conclusions: Cathepsin K deficiency affected mostly the occurrence and composition of lung granulomas,
whereas cathepsin L deficiency significantly reduced their number and cathepsin S inhibition prevented the
formation of granulomas.
Background
Cathepsins K, L and S are members of the papain family of
cysteine proteases that have been recently implicated in
the development of various lung diseases [1]. It is believed
that cathepsins participate in lung tissue remodeling based
on their ability to degrade extra-cellular matrix, their
involvement in the regulation of immune responses and
their potential contribution to the kallikrein-kinin system
[2-5]. In this study, we investigated the roles of cathepsins
K, L, and S in the development of granulomas in mouse
lungs that have features of human granulomas of
sarcoidosis [6]. Sarcoidosis is a systemic disease character-
ized by the presence of noncaseating epithelioid granulo-
mas with a pulmonary involvement in ~90% of the
patients [7,8]. Cathepsins K, L, and S are expressed by
lung macrophages, fibroblasts, and epithelial cells [9].
Significant expression of cathepsin K was first found in
granulomas induced by Echinococcus granulosus in
bovine lung [10]. A strong expression of cathepsin K was
also observed in epithelioid and multinucleated giant cells
(MGCs) in patients with sarcoidosis and tuberculosis
[11,12]. The presence of active forms of cathepsins K, L
and S was found in bronchoalveolar lavage fluids from
patients with sarcoidosis [13]. Recently, we described that
Apoe-/- mice fed a cholate-containing high fat diet develop
lung granulomas that have many features of human
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such granulomas have shown strong immunostaining for
cathepsin K suggesting that this protease might be
involved in granuloma formation or resorption (6).
Similarly to cathepsin K, cathepsins L and S are able
to degrade major extracellular proteins [14] but they are
also involved in immune responses [15,16]. Since cathe-
psins L and S play significant role in antigen presenta-
tion and T cell selection [15,17] and the formation of
granulomas has been linked to T cell activation [18-21],
the disruption of cathepsins L and S activities might
affect the development of granulomas.
Thus, based on the strong expression of cathepsin K in
granulomas and the pivotal role of cathepsins S and L in
the antigen presentation and T-cell selection, we hypothe-
sized that the disruption of these protease activities might
interfere with lung granuloma formation. In this study, we
investigated the effect of cathepsin K and L deficiencies
and cathepsin S inhibition on the development of lung
granulomas in Apoe-/- mice on Paigen diet.
Methods
Animals
T h r e eg r o u p so fm i c ew e r eu s e d :a p o l i p o p r o t e i nE - d e f i -
cient (Apoe-/-) mice (Jackson Laboratories), double
knockout mice lacking apolipoprotein E and cathepsin
K( Apoe-/- Ctsk-/-) (n = 10) and double knockout mice
lacking apolipoprotein E and cathepsin L (Apoe-/-
Ctsl-/-) (n = 19). Double knockout Apoe-/- Ctsk-/- and
Apoe-/- Ctsl-/- mice were generated by crossing Apoe-/-
with the Ctsk-/- or Ctsl-/- mice as previously described
[22]. Ctsk-/- and Ctsl-/- mice were kindly provided by
Drs. P. Saftig (University of Kiel, Germany) and C.
Peters (University of Freiburg, Germany). The single
cathepsin deficiencies have the following phenotypes:
Cathepsin K-deficient mice show an osteopetrotic phe-
notype with excessive trabeculation of the bone-marrow
space [23] and increased fibrosis in lungs after treatment
with bleomycin [24]. Cathepsin L-deficient mice defi-
cient mice develop periodic hair loss and epidermal
hyperplasia [25].
The following primer sequences were used for ApoE:
5"-GCCTAGCCGAGGGAGAGCCG-3"; 5"-TGTGAC
TTGGGAGCTCTGCAGC-3"; 5"-GCCGCCCCGACTG-
CATCT-3"; for cathepsin K: 5"-GCCACACCCACACC
CTAGAAG-3"; 5"-ACA AGT GTA CAT TCC CGT
ACC-3"; and for cathepsin L: 5"-GGAGGGAGAGCGA-
TATGGG-3"; 5"-TTCCTCATTGGTCTT-CCG-3"; 5"-
CGGAGAACCTGCGTGCAATCC-3”. At 6 weeks of age
mice were switched from normal to Paigen fat diet
(HFD) which contained 18% fat, 1% cholesterol and 0.5%
cholate; Test diet 57W4; Purina Mills. LLC, St. Louis,
MO). After 16 weeks on HFD, mice were euthanized
after overnight fasting by exsanguination under xylazine-
ketamine anesthesia. Another two groups of Apoe-/-
mice were studied after 8 weeks on HFD, one group
received high fat diet alone (n = 12) and another received
the same diet plus 0.01% w/w cathepsin S inhibitor (n =
12). The medicated diet was formulated by mixing the
chow in meal form with finely dispersed crystalline,
orally-active inhibitor to obtain a uniform distribution.
The cathepsin S inhibitor (cpd 6 in [26]) was dosed as
the sulfoxide prodrug (cpd 7 (Figure 1) in [26]) which is
rapidly converted into the active sulfone inhibitor in vivo.
The mice consumed approximately 4 g food per day with
no difference in food intake or body weight increase
(average final body weight 23.7 g males, 20.0 g females)
between the two groups. Control Apoe-/- mice used for
CD4
+ cell quantification in lungs were on normal diet for
22 weeks. Single cathepsin K and L null mice on high fat
diet were not evaluated as previous experiments revealed
that the induction of lung granuloma formation by high
fat diet was dependent on the apolipoprotein E deficiency
[6]. All animal procedures were approved by the Cana-
dian Council on Animal Care.
Tissue preparation
After perfusion with ice-cold phosphate-buffered saline
(PBS), lungs and thymuses were fixed in 10% buffered
formalin for 5 hours at 4°C, embedded in paraffin, and
5 μm sections were cut and mounted onto Superfrost/
Plus slides (Fisher-Scientific, Ottawa, ON).
Immunohistochemistry
Sections were dewaxed, rehydrated, blocked with 10%
goat serum in PBS, and incubated overnight at 4°C with
the primary antibody in 1% BSA in PBS: affinity purified
rabbit polyclonal anti-cathepsin K (1: 50) [27], mouse
monoclonal antibody against SMC a-actin (1:100, Bio-
meda, Foster City, CA), rat anti-mouse Mac-3 antibody
(1:100, Pharmingen, San Diego, CA), rabbit polyclonal
anti-mouse osteopontin (1:100, ARP, Belmont, MA),
rabbit polyclonal anti-CD4 (1:100, Abbiotec, San Diego,
CA), rabbit polyclonal anti-CD8 (1:100, ANASPEC, San
Jose, CA) or goat polyclonal anti-cathepsin S and anti-
cathepsin L (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA). Sections stained for cathepsins S and L were
blocked with 10% donkey serum in PBS. As negative
Figure 1 Structure of the cathepsin S inhibitor. Nitrile-based
cathepsin S inhibitor (compound 7 according to [26]).
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same concentrations as the corresponding primary anti-
bodies and for cathepsin K and L antibodies tissue
sections from cathepsin K- and L-deficient mice were
used. Tissue sections were then incubated with the
appropriate secondary antibody: goat anti-rabbit Cy3-
conjugated, goat anti-mouse Cy2-conjugated antibody
(1:200, Rockland, Gilbertsville, PA), goat anti-rat FITC-
conjugated antibody (1:200, Sigma-Aldrich, St. Louis,
MO), and donkey anti-goat Texas Red-conjugated
(1:200 v/v, Jackson ImmunoResearch Laboratories, West
Grove, PA).
Gomori’s trichrome staining
Sections were deparaffinized, hydrated with a graded
alcohol series and distilled water, and placed in pre-
heated Bouin’s solution at 58°C for 10 min. Sections
were stained in Weigert’s iron hematoxylin solution for
5 min, washed under running water for 30 sec, stained
with Gomori’s trichrome solution (Sigma-Aldrich, St.
Louis, MO) for 15 min, placed in 0.5% acetic acid for
10 sec, and then mounted for light microscopy.
Morphometry, collagen content, and cell composition of
granulomas
The areas of granulomas stained positively for Mac-3,
osteopontin, CD4 and CD8, and collagen were quanti-
fied using color threshold and calculated as percentage
o fg r a n u l o m aa r e a .T h es i z eo fg r a n u l o m a sw a sm e a -
sured in mm
2. Trichrome stained sections were used for
the measurement of granuloma size and for the quantifi-
cation of collagen content. Images were captured with a
Leica DMI 6000B microscope (Leica Microsystems, Inc,
Richmond Hill, ON) and analyzed with Openlab 3
software.
Quantification of the number of granulomas,
multinucleated giant cells and CD4-positive cells
Five sections 200 μm apart from each other were ana-
lyzed for each lung. For CD4-positive cell quantification
three pictures per lung section were taken using a 40-
fold magnification, avoiding areas with dominating tra-
cheal or bronchial tissue. The average number of granu-
lomas and multinucleated giant cells per section and the
average number of CD4-positive cells per captured area
for each mouse were used for statistical analyses.
Statistical analysis
Student’s t-tests were performed when values past test
for normal distribution. Data are presented as mean ±
standard deviation. Discontinuous data (such as the
number of granulomas) were analyzed using the Mann-
Whitney U-test. Significance was concluded when
P < 0.05.
Results
Cathepsins K, L and S are expressed in mouse lung
granulomas
Recently, we described that Apoe-/- mice receiving HFD
develop epithelioid lung granulomas with characteristic
features of granulomas of sarcoidosis [6]. Granulomas
were composed of epithelioid cells, macrophages and T
cells, and some granulomas also contained fibroblasts
and multinucleated giant cells (MGCs) [6]. Figure 2A
displays the typical phenotype of granulomas seen in
this model. Similarly to granulomas of sarcoidosis,
mouse lung granulomas were intensively stained for
cathepsin K with the highest immunoreactivity in
epithelioid cells forming the core of the granulomas
(Figure 2B). Analysis of consecutive sections stained for
cathepsins L and S revealed that similarly to cathepsin
K, cathepsin L was prevalently observed in the core of
granulomas, whereas cathepsin S staining was weaker
and uniformly distributed throughout the lung tissue
(Figure 2C, D).
Cathepsin K deficiency increased the incidence of
granulomatous infiltrations in lungs
Similarly to Apoe-/- mice, Apoe-/- Ctsk-/- mice receiving
HFD showed fibrotic changes in lung tissues and the
presence of such inclusions as Schaumann’sb o d i e sa n d
crystalline structures (Figure 3A), which are nonspecific
but are often present in patients with sarcoidosis.
Apoe-/- Ctsk-/- mice also developed inducible bronchus-
associated lymphoid tissues (iBALT) which are usually
induced by inflammatory reactions and are present in
Figure 2 Expression of cathepsins in lung granulomas.
Cathepsins K, L and S are expressed in lung granulomas of Apoe-/-
mice. (A), trichrome stained section shows well-formed lung
granulomas. (B), cathepsin K immunostaining (red - cathepsin K,
blue - nuclei). (C), cathepsin L immunostaining (red - cathepsin L,
blue - nuclei). (D), cathepsin S immunostaining (red - cathepsin S,
blue - nuclei). (A), scale bar 130 μm, (B-D), scale bars 65 μm.
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acute lung injury, such as alveolar monocyte/neutrophil
infiltration and proteinosis, were also observed (Figure
3B and 3C). In Apoe-/- mice, 41% of the animals dis-
played lung granulomas, whereas in their cathepsin
K-deficient littermates this number reached 88%
(table 1). Notable differences in the morphology of gran-
ulomatous infiltrations were also observed. In some lung
areas, the presence of epithelioid cells did not result in
the development of well-formed and ball-shaped granu-
lomas that were predominant in cathepsin K-expressing
mice. In cathepsin K-knockout mice, epithelioid cells
were often organized in amorphous or ring-like struc-
tures formed by epithelioid cells (Figure 3D) and granu-
lomas often contained an accumulation of fibroblast-like
shaped cells showing positive staining for a-actin (Fig-
ure 3E). In some lung areas, extensive accumulation of
collagen fibers and epithelioid cells covered large areas
between airways and blood vessels (Figure 3F, G). In
more fibrotic areas that had honeycombing appearance,
individual epithelioid cells were randomly dispersed (Fig-
ure 3H). The average size of granulomas was significantly
smaller in cathepsin K-deficient mice (see below) when
compared to cathepsin K-expressing littermates, but
some granulomas reached comparatively large sizes (Fig-
ure 2I) that might be related to changes in granuloma
development in the absence of cathepsin K.
Analysis of lung granuloma composition revealed that
cathepsin K-deficient mice contained significantly higher
number of MGCs per lung section (Figure 4A-C). Granu-
lomas contained foreign body-type MGCs, with random
distribution of nuclei (Figure 4A) and Langhans-type
MGCs with horseshoe-like arrangements of nuclei
(Figure 4B). Epithelioid cells and MGCs were intensively
Figure 3 Structural changes in lungs of Apoe-/-Ctsk-/- mice. (A), extensive fibrosis with Schaumann’s bodies (arrowhead) and crystalline
structures (arrow). (B), inducible bronchus-associated lymphoid tissues (iBALT) and alveolar monocyte/neutrophilic infiltration. (C), proteinosis. (D),
ring-like structures formed by epithelioid cells. (E), smooth muscle cell a-actin positive cells in granulomas (green - smooth muscle cell a-actin,
blue - nuclei). (F), accumulation of epithelioid cells between layers of collagen fibers (* shows area magnified on G). (H), individual epithelioid
cells in fibrotic areas with honeycombing appearance. (I), two granulomas with relatively large size. (A-D, F-I), trichrome stained sections. (A-E and
I), scale bars 65 μm; (F), scale bar 260 μm; (G), scale bar 30 μm; (H), scale bar 130 μm.
Table 1 Percentage of mice with granulomas, proteinosis
or iBALT in lungs
Apoe-/-
(16 w)
Apoe-/-
Ctsk-/-
(16 w)
Apoe-/-
Ctsl-/-
(16 w)
Apoe-/-
(8 w)
Apoe-/-
(cat S inh)
(8 w)
Granulomas 41 88 31 41 -
Proteinosis 17 11 26 9 8
iBALT 47 77 31 36 15
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Mac-3, was not expressed in giant cells (Figure 4D-F).
Granuloma cell composition analyzed by immunohisto-
chemical staining did not reveal significant differences in
the amount of CD4
+ and CD8
+ T cells as well as Mac-3
(macrophage marker) and osteopontin positive cells
(epithelioid cells marker) in Apoe-/- Ctsk-/- mice when
compared to their cathepsin K-expressing littermates
(Figure 4G and [6]). The collagen content was signifi-
cantly higher in granulomas of mice lacking cathepsin K
(Figure 4H).
Cathepsins K and L deficiencies and cathepsin S
inhibition decreases the number and size of lung
granulomas
Apoe-/- mice lacking cathepsin K have shown a higher
incidence of lung granulomas compared to Apoe-/- mice
(table 1), but the size of granulomas was significantly
smaller (Figure 5A, B, D). Cathepsin L deficiency
resulted in the lower incidence and smaller size of
granulomas (table 1 and Figure 5C, D). The number of
granulomas decreased dramatically from an average of
34 per lung section in Apoe-/- mice to one in Apoe-/-
Ctsl-/- mice (Figure 5E). After 8 weeks of HFD the size
of granulomas in Apoe-/- mice was smaller compared to
16 weeks of diet (12.6 ± 3.66 mm
2 vs. 20.8 ± 4.3) but
granulomas were still well-formed (Figure 5F) and simi-
l a r l yt o1 6w e e k s ,t h e yw e r ep r e s e n ti n4 1 %o fm i c e
(table 1). In cathepsin S inhibitor-treated mice only indi-
vidual epithelioid cells without well-formed granulomas
were observed (Figure 5G) and epithelioid cells were
present in 30% of mouse lungs. After one week of dos-
ing, morning blood levels of active inhibitor reached
1.0 ± 0.16 μM (n = 6 animals). This concentration likely
approximates the peak blood level as mice feed predo-
minantly at night. Cathepsin S is highly expressed in the
spleen and antigen-presenting cells and its inhibition
impairs antigen presentation and causes a build-up of
intermediate invariant chain (Ii) breakdown products
[29,30]. Previously, we reported significant accumulation
Figure 4 Granuloma composition in cathepsin K-deficient mice. (A), granuloma with several foreign body-type MGCs. (B), granuloma with
Langhans-type MGC (C), cathepsin K-deficient mice had significantly higher number of MGCs per lung section, (* - p < 0.05 when compared to
Apoe-/- mice). (D), Mac-3 positive cells in granuloma (green - Mac-3, blue - nuclei), (E), osteopontin-containing epitheloid and giant cells (red -
osteopontin, blue - nuclei), (F), merge of D and E. (G), percentage of granuloma area stained for Mac-3, osteopontin, CD4 and CD8. (H) The
collagen-stained area was quantified using color threshold and calculated as percentage of granuloma area (* - p < 0.05 when compared to
Apoe-/- mice). (A, D-F), scale bars 30 μm, (B), scale bar, 20 μm.
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bitor-treated mice after 8 weeks of HFD that provides
an evidence of an efficient inhibition of cathepsin S [31].
Effect of cathepsins on thymus hypertrophy
In addition to fibrosis and granulomatous inflammation
in lung, HFD induces fibrotic changes and hypertrophy
in the thymus. Previously, we observed that after
16 weeks on HFD, Apoe-/- mice had more than a 3-fold
increase in thymus weight compared to their littermates
on normal diet [6]. Cathepsin K and L deficiencies and
cathepsin S inhibition did not prevent the development
of fibrotic changes in thymi. In all mice, an accumula-
tion of collagen fibers and the presence of MGCs were
observed (Figure 6A-C). But the thymus hypertrophy
was dependent on cathepsin activities: mice receiving
the cathepsin S inhibitor, or lacking cathepsin K, have
shown insignificantly lower weights of thymi, whereas in
Apoe-/- Ctsl-/- mice thymi had more than 5 times smal-
ler weights when compared to Apoe-/- mice (Figure 6D,
F). As cathepsin L-deficient mice had a lower total body
weight, a ratio between thymus and total body weight
was evaluated. This proportion was significantly lower
in cathepsin K-null mice and more than 4-times smaller
in cathepsin L-deficient mice (Figure 6E).
Accumulation of CD4-positive cells in lungs is affected by
cathepsin S inhibitor and cathepsin L deficiency
The formation of lung granulomas was accompanied by
am o r et h a n5 - f o l di n c r e a s ei nt h en u m b e ro fC D 4 -
positive cells in lungs of mice on HFD when compared
to mice on normal diet (Figure 7A, B). Cathepsin K defi-
ciency did not affect the CD4 population when com-
pared to Apoe-/- mice. In contrast, disruption of
cathepsin L and S activities resulted in an 18% and 43%
lower accumulation of CD4-positive cells in lungs
(Figure 7B, C).
Discussion
The formation of lung granulomas results in an exten-
sive extracellular matrix remodeling. Collagen and elas-
tin are the major components of the pulmonary matrix
Figure 5 Changes in granuloma size and numbers. Granulomas in Apoe-/- (A), Apoe-/-Ctsk-/- (B) and Apoe-/-Ctsl-/- mice after 16 weeks on HFD (C).
(D), size of granulomas was significantly smaller in cathepsin K- and L-deficient mice. (E), number of granulomas in cathepsin L-deficient mice was
dramatically decreased. (F), granulomas in Apoe-/- mice after 8 weeks on HFD. (G), Apoe-/- mice treated with cathepsin S inhibitor developed only
individual epithelioid cells after 8 weeks on HFD. (A-C, F, G), trichrome stained sections, scale bars 65 μm. * - p < 0.05 when compared to Apoe-/- mice.
Samokhin et al. Respiratory Research 2011, 12:13
http://respiratory-research.com/content/12/1/13
Page 6 of 9a n di ti sb e l i e v e dt h a tac o o p e r a t i v ea c t i o no fm u l t i p l e
enzymes is required for its turnover. Cathepsin K has a
unique ability to cleave highly efficiently triple helical
collagen at multiple sites and to act as a potent elastase
as well [32]. Its strong expression in lung granulomas
suggested an important role in granuloma formation
and resolution, and indeed, lungs of Apoe-/- Ctsk-/-
mice showed significant differences in granuloma
appearance, size, and composition. The increased inci-
dence of lung granulomas in cathepsin K-deficient mice
(88% vs. 41%) correlates with the increased collagen
fibers deposition (10% vs 20%) that may consequently
result in a delayed granuloma resolution. Lung granu-
loma formation and their spontaneous resolution as
commonly observed in patients with sarcoidosis [33]
require remodeling of the extracellular matrix. It is
tempting to speculate that the increased amount of col-
lagen in granulomas (Figure 4H) and the presence of
abundant collagen fibers between epithelioid cells in
areas without well-formed granulomas (Figure 3F, G) in
Ctsk-/- mice is due to the lack of the collagenase activity
of cathepsin K. This accumulation of collagen fibers
might also be responsible for the smaller number and
size of granulomas. In our measurements, accumulations
of epithelioid cells were considered as granulomas only
when they were present as well-formed and ball-shaped
structures that are characteristic for sarcoidosis. In
Apoe-/- Ctsk-/- mice, epithelioid cells were often
Figure 6 Fibrosis and MGCs in thymus. (A), fibrotic thymus in Apoe-/-Ctsl-/- mice. (B), foreign body type MGCs with random distribution of
nuclei in Apoe-/-Ctsk-/- mice. (C), Langhans-type MGCs with horseshoe-like arrangement of nuclei in cathepsin S inhibitor treated mice. (D),
cathepsin L deficiency prevents hypertrophy of thymus. (E), proportion of thymus to total body weight was significantly lower in cathepsin K-
and L-deficient mice. (F), cathepsin S inhibitor treatment did not prevent thymus hypertrophy. * - p < 0.05 when compared to Apoe-/- mice. A-C,
trichrome staining. (A), scale bar 130 μm, (B, C), scale bars 30 μm.
Figure 7 Effect of cathepsins on the amount of CD4-positive cells in lungs. The number of CD4-positive cells (A) was more than a 5-times
higher in lungs of Apoe-/- mice as a result of HFD-feeding (B). Apoe-/- Ctsk-/- mice did not reveal a significant difference in its CD4 population,
whereas Apoe-/- Ctsl-/- mice showed less dramatic accumulation of CD4
+ cells when compared to Apoe-/- mice (* - p < 0.05 between Apoe-/-
mice on HFD and Apoe-/- mice on normal diet; * - p < 0.05 when compared to Apoe-/- mice on HFD). Cathepsin S inhibitor treatment resulted
in a significant reduction of CD4
+ cells in lungs of mice on HFD (C, * - p < 0.05 when compared to mice on HFD without inhibitor). (A), Scale
bar 30 μm.
Samokhin et al. Respiratory Research 2011, 12:13
http://respiratory-research.com/content/12/1/13
Page 7 of 9observed forming ring-like structures with dispersed col-
lagen fibers, or were randomly distributed in fibrotic
areas (Figure 3D, H).
The cell composition of granulomas in cathepsin
K-deficient mice was also changed. They contained a
significantly higher number of MGCs. This type of cells
is formed by the fusion of cells from the monocyte-
macrophage lineage [34]. In atherosclerotic plaques
from Apoe-/- Ctsk-/- mice, macrophages have an
increased size [35] and microarray analyses have
revealed the upregulation of several macrophage genes,
including CD36 [36]. Since CD36 participates in macro-
p h a g ef u s i o n[ 3 7 ] ,w es u g g e s tt h a ti tm i g h tb er e s p o n s i -
ble for the increased number of MGCs in cathepsin
K-deficient mice. The disruption of cathepsins L and S
activities resulted in a more significant effect on granu-
loma formation. Cathepsin L deficiency reduced the size
and the number of lung granulomas whereas mice trea-
ted with the cathepsin S inhibitor did not develop well-
formed granulomas.
Analysis of available literature data suggests that the
preventive effect of cathepsin L deficiency or cathepsin
S inhibition on lung granuloma development may not
only depend on their extracellular matrix-degrading
activities, but on their involvement in antigen presenta-
tion as well [17,38]. Cathepsin S is expressed in B cells,
macrophages, and dendritic cells and is required for
invariant chain (li) degradation and antigen processing
[30]. Cathepsin S-deficient mice have decreased MHC
class II presentation in B and dendritic cells, and a
reduced number of CD4
+ T-cells [15]. On the other
hand, cathepsin L is expressed in cortical thymic epithe-
lial cells and macrophages and is responsible for li
degradation in CD4
+ T cell selection in the thymus [17].
Cathepsin L-deficient mice have a reduction in their
numbers of CD4
+ cells in thymus and peripheral organs
[39]. The roles of cathepsins S and L on the functions
of CD4
+ may have a direct influence on sarcoidosis
development. T cell activation is mandatory for the
development of granulomatous reactions and CD4
+ T
cells of the Th1-type are essential for the formation and
the maintenance of granulomas [18-21]. The decreased
amount of CD4
+ cells in lungs of mice lacking cathepsin
L or treated with cathepsin S inhibitor (Figure 7B, C)
supports the suggestion that the effect of these two
cathepsins on the granuloma formation is related to
their role in antigen presentation and T-cell selection.
In addition to its involvement in antigen presentation,
cathepsin L has been described to play a role in T-cell
actin polymerization, shape polarization, chemotaxis.
Cathepsin L deficiency significantly decreases the
expression of laminin, fibronectin, and collagens I and II
in thymus of cathepsin L-deficient mice [40]. This might
partially explain why Apoe-/- Ctsl-/- mice had
significantly smaller thymi compared to Apoe-/- mice
(Figure 7D, E).
In conclusion, our results show that the disruption of
cathepsin L and S activities prevents the development of
lung granulomas, whereas cathepsin K deficiency results
in altered granuloma composition in mice. These results
suggest that interventions in cathepsin S and L activities
may yield a therapeutic benefit for patients with sarcoi-
dosis, i.e., a potential prevention of disease progression.
Such an approach, however, would require extreme cau-
tion as both cathepsins have been described as critical
participants in antigen presentation and their inhibition
may result in increased infection and cancer rates.
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